A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study
Robins, H. Ian, Zhang, Peixin, Gilbert, Mark R., Chakravarti, Arnab, de Groot, John F., Grimm, Sean A., Wang, Fen, Lieberman, Frank S., Krauze, Andra, Trotti, Andy M., Mohile, Nimish, Kee, Andrew Y. JVolume:
126
Language:
english
Journal:
Journal of Neuro-Oncology
DOI:
10.1007/s11060-015-1966-z
Date:
January, 2016
File:
PDF, 527 KB
english, 2016